Cardiac MRI in Fabry disease
Frontiers in Cardiovascular Medicine · 02.02.2023 · 9
DOI: 10.3389/fcvm.2022.1075639 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 02.02.2023. Verfasst von Muhammad Umer und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, University of Louisville, Louisville, KY, United States. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Fabry disease is a rare, progressive X-linked inherited disorder of glycosphingolipid metabolism due to a deficiency of α-galactosidase A enzyme. It leads to the accumulation of globotriaosylceramide within lysosomes of multiple organs, predominantly the vascular, renal, cardiac, and nervous systems. Fabry cardiomyopathy is characterized by increased left ventricular wall thickness/mass, functional abnormalities, valvular heart disease, arrhythmias, and heart failure. Early diagnosis and treatment are critical to avoid cardiac or renal complications that can significantly reduce life expectancy in untreated FD. This review will focus on the role of cardiovascular magnetic resonance imaging in the diagnosis, clinical decision-making, and monitoring of treatment efficacy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiology, University of Louisville, Louisville, KY, United States.
Zitieren
APA
Umer, M., & Kalra, D. K. (2023). Cardiac MRI in Fabry disease. Frontiers in Cardiovascular Medicine, 9. https://doi.org/10.3389/fcvm.2022.1075639
Vancouver
Umer M, Kalra DK. Cardiac MRI in Fabry disease. Frontiers in Cardiovascular Medicine. 2023;9. doi:10.3389/fcvm.2022.1075639
BibTeX
@article{Umer2023,
author = {Umer, Muhammad and Kalra, Dinesh K},
title = {Cardiac MRI in Fabry disease},
journal = {Frontiers in Cardiovascular Medicine},
year = {2023},
volume = {9},
doi = {10.3389/fcvm.2022.1075639}
}
EUVIMED